CRL (CRL) Form 144: 75,000-share resale via UBS Financial Services

Rhea-AI Filing Summary

CRL notified a proposed sale of 75,000 shares of Common Stock through UBS Financial Services. The filing lists an aggregate offering price of $16,875,000.00 and reports 48,167,730 shares outstanding as of 06/29/2026. The listing includes multiple RSU/PSU lots with grant and vesting dates and share counts.

Insights

Securities Counsel

Form 144 notice documents a proposed resale of restricted/common shares via a broker.

Form 144 is a statutory notice required when an affiliate proposes a sale of restricted or control securities. The filing here lists 75,000 shares and an aggregate price of $16,875,000.00.

Timing and final execution depend on market sales and compliance with resale conditions; the filing includes multiple RSU/PSU grant/vesting entries that explain the origin of the shares.

Key Figures

Shares covered: 75,000 shares Aggregate offering price: $16,875,000.00 Shares outstanding: 48,167,730 shares

3 metrics

Shares covered 75,000 shares listed alongside broker entry

Aggregate offering price $16,875,000.00 aggregate price shown on same line as shares

Shares outstanding 48,167,730 shares reported as of <date>06/29/2026</date>

Key Terms

Form 144, RSU/PSU, aggregate offering price

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU/PSU financial

"Common | 02/07/2020 | RSU/PSU | Issuer | | | 6260"

aggregate offering price financial

"Common | UBS Financial Services, Inc. ... | 75000 | 16875000.00"

The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.

FAQ

What does CRL's Form 144 filing mean for shareholders?

It notifies a proposed sale of restricted or control securities by an affiliate. The notice lists 75,000 shares with an aggregate price of $16,875,000.00 and identifies UBS Financial Services as the broker involved in the potential resale.

How many CRL shares are covered by the Form 144 filing (CRL)?

The filing lists 75,000 shares of Common Stock. It also shows an aggregate offering price of $16,875,000.00 and reports 48,167,730 shares outstanding as of 06/29/2026 in the same line.

Who is the broker handling the sale in CRL's Form 144?

UBS Financial Services, Inc. is named as the broker. The filing shows the broker's address at Eleven Madison Avenue, New York, and lists the sale quantity and aggregate price alongside that broker entry.

Do the RSU/PSU lines in the filing affect the sale disclosure?

The RSU/PSU entries list grant or vesting dates and share counts tied to the securities. They document the origin of restricted awards (e.g., grants dated 01/27/2023: 19,390 shares) included in the overall resale notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/29/2026 - 04:45 PM Accepted by SEC EDGAR 06/29/2026 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001141722
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
SEC File Number	001-15943
Address of Issuer	251 BALLARDVALE ST WILMINGTON MASSACHUSETTS 01887
Phone	781-222-6000
Name of Person for Whose Account the Securities are To Be Sold	FOSTER JAMES C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	75000	16875000.00	48167730	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2020	RSU/PSU	Issuer			6260	02/07/2020	NA
Common	02/20/2025	RSU/PSU	Issuer			6075	02/20/2025	NA
Common	01/31/2025	RSU/PSU	Issuer			12781	01/31/2025	NA
Common	11/14/2023	RSU/PSU	Issuer			5620	11/14/2023	NA
Common	05/29/2023	RSU/PSU	Issuer			1597	05/29/2023	NA
Common	05/29/2024	RSU/PSU	Issuer			1597	05/29/2024	NA
Common	01/29/2024	RSU/PSU	Issuer			3119	01/29/2024	NA
Common	01/27/2023	RSU/PSU	Issuer			19390	01/27/2023	NA
Common	05/29/2022	RSU/PSU	Issuer			1560	05/29/2022	NA
Common	01/29/2021	RSU/PSU	Issuer			4050	01/29/2021	NA
Common	01/28/2022	RSU/PSU	Issuer			12951	01/28/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for James Foster
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)